Saturday, May 27, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

Development of MAGPIX Immunoassays for Lassa, Chikungunya, Ebola

by Global Biodefense Staff
April 20, 2015
USAMRIID U.S. Army Medical Research Institute of Infectious Diseases

The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) is soliciting development and deployment of MAGPIX-based immunoassays which will comprise part of an orthogonal detection system supporting the current Ebola outbreak, as well as other DoD pathogen detection requirements.

Critical detection reagents are sought for the development of immunoassays including: Ebolavirus (EBOV), Lassa fever virus (LASV), Marburg virus (MARV), chikungunya virus, (CHKV), Crimean Congo hemorrhagic fever virus (CCHF), and the Eastern, Western, and Venezuelan equine encephalitis viruses (VEE, WEE and EEE).

While the first period will be devoted to the production of proteins from LASV and the Zaire strain of the Ebola virus (ZEBOV) based on USAMRIID’s current mission, option periods may include the same production or other appropriate targets as determined by USAMRIID’s mission.

The period of performance will be a one year base period with four option years.

Further details are available via Solicitation Number: W81XWH-15-R-0015. The response deadline is May 18, 2015.

Tags: DengueEbolaEquine EncephalitisLassa FeverUSAMRIID

Related Posts

Vials of finished vaccines
Funding News

UK Biomanufacturing Fund to Bolster Supply Chain Resilience and Pandemic Preparedness

May 26, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
two soldiers are in head-to-toe hazmat suits with respirator masks while tending to a mannikin on a stretcher
CBRNE

Protection from Biothreats: DOD to Modernize Medical Countermeasures Development

January 10, 2023
Load More

Latest News

Vials of finished vaccines

UK Biomanufacturing Fund to Bolster Supply Chain Resilience and Pandemic Preparedness

May 26, 2023
Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance

Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance

April 26, 2023
Biodefense Headlines – 25 April 2023

Biodefense Headlines – 25 April 2023

April 25, 2023
Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

April 20, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2023 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2023 Stemar Media Group LLC